Retracted: Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients Via Analysis of Competing Endogenous RNA (ceRNA) Network

Overview

Journal Dis Markers

Publisher Wiley

Specialty Biochemistry

Date 2023 Aug 4

PMID 37538089

Authors

Disease Markers

Affiliations

Soon will be listed here.

Abstract

[This retracts the article DOI: 10.1155/2023/1766080.].

Citing Articles

Unraveling the role of the circadian clock genes in cervical squamous cell carcinoma and endocervical adenocarcinoma: A prognostic indicator for prognostic, immunotherapy response, and chemotherapy sensitivity.

Xu J, Huang X, Gou S, Luo H, Zeng S, Zhang Q J Cancer. 2024; 15(9):2788-2804.

PMID: 38577592 PMC: 10988312. DOI: 10.7150/jca.94063.

References

Dong Y, Wen W, Yuan T, Liu L, Li X . Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network. Dis Markers. 2023; 2023:1766080. PMC: 9936453. DOI: 10.1155/2023/1766080. View